EvidenceAlerts

Alerts from premier clinical journals, pre-rated for quality and clinical relevance to support evidence-based clinical decisions.

[EvidenceAlerts @EvidenceAlerts]

#EBM EvidenceAlerts | Long-term survival benefit of ramipril in patients with acute myocardial infarction complicated by heart failure. https://t.co/qJf1jOPFA5

[EvidenceAlerts @EvidenceAlerts]

#COVID19 Free full text available! #coronavirus #covidNSAIDs EvidenceAlerts | Use of non-steroidal anti-inflammatory drugs and risk of death from COVID-19: an OpenSAFELY cohort analysis based on two cohorts. https://t.co/5HkJMzleyP

[EvidenceAlerts @EvidenceAlerts]

#COVID19 Free full text available! #coronavirus #covidScreening EvidenceAlerts | Universal screening for SARS-CoV-2 infection: a rapid review. https://t.co/3Hf3ieuAOM

[EvidenceAlerts @EvidenceAlerts]

#EBM Free full text available! EvidenceAlerts | Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function: Insights From EMPEROR-Reduced. https://t.co/vlw6U2KL3v

[COVID-19 Evidence Alerts @COVID19Evidence]

#COVID19 Free full text! #coronavirus Maternal and Neonatal Characteristics and Outcomes of COVID-19 in Pregnancy: An Overview of Systematic Reviews. https://t.co/WBcvwi9iVh

[COVID-19 Evidence Alerts @COVID19Evidence]

#COVID19 Free fulltext! #coronavirus Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19: A Randomized Clinical Trial. https://t.co/cQcMPptG0t

[COVID-19 Evidence Alerts @COVID19Evidence]

#COVID19 Free full text access! #coronavirus Diagnosing COVID-19 pneumonia in a pandemic setting: Lung Ultrasound versus CT (LUVCT) - a multicentre, prospective, observational study. https://t.co/I2KdLpYUqU

[EvidenceAlerts @EvidenceAlerts]

#EBM Free full text! EvidenceAlerts | Procalcitonin to Reduce Long-Term Infection-associated Adverse Events in Sepsis. A Randomized Trial. https://t.co/Q3DspYpgt7

[COVID-19 Evidence Alerts @COVID19Evidence]

#COVID19 Free full text access! #coronavirus Development and external validation of a COVID-19 mortality risk prediction algorithm: a multicentre retrospective cohort study. https://t.co/sKw4QbbIsZ

[COVID-19 Evidence Alerts @COVID19Evidence]

#COVID19 Free full text access! #coronavirus A Symptom-Based Rule for Diagnosis of COVID-19. https://t.co/igNvKpcXZY

[COVID-19 Evidence Alerts @COVID19Evidence]

#COVID19 Free full text access! #coronavirus #CovidSalivaTest The Sensitivity and Costs of Testing for SARS-CoV-2 Infection With Saliva Versus Nasopharyngeal Swabs : A Systematic Review and Meta-analysis. https://t.co/evkH1P4yzt

[EvidenceAlerts @EvidenceAlerts]

#EBM EvidenceAlerts | Empagliflozin and health-related quality of life outcomes in patients with heart failure with reduced ejection fraction: the EMPEROR-Reduced trial. https://t.co/J78Gl8yiO7

[EvidenceAlerts @EvidenceAlerts]

#EBM Free full text access! EvidenceAlerts | Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials. https://t.co/JPSsxRpxOG

[EvidenceAlerts @EvidenceAlerts]

#EBM EvidenceAlerts | Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease. https://t.co/ux4NKG2336

[EvidenceAlerts @EvidenceAlerts]

#EBM #QI #KT EvidenceAlerts | Strategies to reduce the use of low-value medical tests in primary care: a systematic review. https://t.co/kSjO1AC8gl

[EvidenceAlerts @EvidenceAlerts]

#EBM #HIV EvidenceAlerts | Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 48-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority study. https://t.co/6DgU6fqww9

[COVID-19 Evidence Alerts @COVID19Evidence]

#COVID19 #coronavirus #covidvaccine #vaccine Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. https://t.co/4fJNG0cInN

[EvidenceAlerts @EvidenceAlerts]

#EBM #CV EvidenceAlerts | Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial. https://t.co/jIcvRlIUPM

[EvidenceAlerts @EvidenceAlerts]

#EBM Free full text! EvidenceAlerts | Adult Advanced Life Support: 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations. https://t.co/kKrFqcr0VE

[COVID-19 Evidence Alerts @COVID19Evidence]

#COVID19 #coronavirus Free full text! #covid AGA Institute Rapid Review and Recommendations on the Role of Pre-Procedure SARS-CoV-2 Testing and Endoscopy. https://t.co/ir4OmRiuHX